When the measles vaccine came out, and why 1963 to 1967 matters

When Did the Measles Vaccine Come Out?

Measles is a highly contagious viral infection that once sickened hundreds of thousands of Americans each year, causing serious complications and even death. The introduction of a safe and effective vaccine changed that trajectory dramatically—and the period from 1963 to 1967 marks a pivotal chapter in public health history.

---

The Burden of Measles Before 1963

• In the decade before vaccine introduction, the U.S. averaged about 500,000 reported cases and 400–500 deaths from measles each year.
• Complications—including pneumonia, encephalitis (brain swelling), hearing loss and severe diarrhea—were common, especially in young children.
• Quarantine measures and school closures were sometimes the only tools to slow outbreaks.

---

Development of the First Measles Vaccine

1. Early Research (1954–1962)

   • In the mid-1950s, virologists like John F. Enders began adapting wild measles virus strains in tissue culture, aiming to weaken (attenuate) the virus so it could safely trigger immunity.
   • By growing the virus in chick embryo fibroblasts and through repeated culture passages, researchers produced an attenuated strain known as “Edmonston B.”

2. Clinical Trials and Safety Testing

   • Late-phase trials in children and young adults showed the Edmonston B strain vaccine was well tolerated and stimulated protective antibodies.
   • Side effects were generally mild: low-grade fever, rash or tenderness at the injection site.

3. Licensure in 1963

   • On April 15, 1963, the U.S. Food and Drug Administration licensed the first live attenuated measles vaccine.
   • This date answers the key question: when did the measles vaccine come out? It officially “came out” in spring 1963.

---

Why 1963–1967 Matters

Rapid Rollout and Recommendations

• 1963

  • Initial doses were made available to pediatricians and health departments.
  • The American Academy of Pediatrics (AAP) and Centers for Disease Control (CDC) recommended vaccination for children aged 1–10 years.

• 1964

  • State health authorities began school-entry requirements for measles immunization in many regions.
  • Federal grants supported mass immunization programs targeting preschool and elementary school populations.

• 1965–1966

  • More than 10 million doses were administered nationwide.
  • Measles surveillance systems tracked a sharp decline in reported cases.

• 1967

  • The U.S. government expanded funding for community clinics, migrant health centers and Head Start programs to ensure broader access.
  • By year’s end, reported measles cases had fallen by over 95%, from roughly half a million in 1963 to around 22,000 in 1967.

Key Impacts by 1967

• 
Case counts and hospitalizations plummeted.
• Measles-related deaths became rare in vaccinated populations.
• The success of the Edmonston B vaccine laid the groundwork for a combined measles-mumps-rubella (MMR) vaccine licensed in 1971.
• Public confidence in immunization programs grew, setting a model for future vaccines.

---

Measles Today: Why Vaccination Still Matters

• Although measles was declared eliminated in the U.S. in 2000, importations and clusters continue when vaccination rates dip.
• Outbreaks can resurge rapidly in communities where fewer children are immunized.
• Maintaining at least 95% coverage is critical to protecting infants, pregnant women and people with weakened immune systems who can’t be vaccinated.

---

Recognizing Measles Symptoms

Common early signs (after a 10–14 day incubation) include:

• High fever
• Red, watery eyes (conjunctivitis)
• Runny nose and cough
• Flat red spots that develop into a raised rash

If you or your child develop these symptoms—especially during a local outbreak—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you determine whether to seek in-person care.

---

Next Steps: Vaccination and Medical Advice

1. Check Immunization Status

   • Ensure all children receive one dose at 12–15 months and a second dose at 4–6 years, or per your provider’s schedule.

2. Talk to Your Doctor

   • If you have concerns about measles, vaccine timing or immune-compromising conditions, discuss them with a healthcare professional.

3. Seek Immediate Care for Severe Symptoms

   • High fever, difficulty breathing or signs of dehydration require prompt medical attention.

For any life-threatening or serious concerns, always speak to a doctor without delay.

---

Summary

• The first measles vaccine “came out” in April 1963.
• From 1963 to 1967, rapid adoption and expanded public programs drove a dramatic (>95%) drop in U.S. measles cases.
• Maintaining high vaccination coverage today remains essential to prevent resurgence.
• Use tools like the free Ubie Symptom Checker to assess early symptoms, and always speak to a doctor for serious or life-threatening issues.